X4 Pharmaceuticals (XFOR) Tops Q3 EPS by 14c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.01), $0.14 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Playboy to buy back 16.6M shares from Fortress at $1.05 each
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings